Adaptive Biotechnologies
Michael Eddy has over 19 years of experience in the biotechnology and pharmaceutical industries, currently serving as Director of National Strategic Accounts at Adaptive Biotechnologies Corp. since October 2017. His diverse roles at Adaptive include Associate Director and Regional Sales Manager within Diagnostic Hematology. Prior to this, Michael held a Key Account Manager position at NanoString Technologies, Inc., and worked as a Hematology Oncology Consultant at Celgene. Michael's career began at Eli Lilly, where Michael spent over a decade as an Executive Sales Representative. Michael earned a Bachelor of Science degree in Chemical and Biomolecular Engineering from the University of South Florida between 1988 and 1993.
This person is not in any teams
This person is not in any offices
Adaptive Biotechnologies
17 followers
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision.